Innovative skin cancer drug available on Cancer Drugs Fund

Patients with a type of advanced skin cancer have a new treatment option as pembrolizumab, also known as Keytruda, has been recommended for use on the Cancer Drugs Fund.

Read article

NICE recommends cutting-edge therapy for young people with blood cancer

NICE has recommended a pioneering cancer treatment, CART-cell therapy, for people under the age of 25 with leukaemia.

Read article

NICE to retire Guidance app

Following improved access and optimisation of the website, the NICE guidance app will no longer be available for download with plans to phase it out by January 2019.

Read article

Jeanette Kusel is appointed as director for NICE Scientific Advice

NICE has announced the appointment of Jeanette Kusel as director for NICE Scientific Advice.

Read article

Latest news headlines